SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-286254
Filing Date
2020-11-05
Accepted
2020-11-05 07:47:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d922774ds3.htm S-3 369601
2 EX-4.2 d922774dex42.htm EX-4.2 353777
3 EX-5.1 d922774dex51.htm EX-5.1 25940
4 EX-23.1 d922774dex231.htm EX-23.1 1521
5 GRAPHIC g922774g25h31.jpg GRAPHIC 34435
6 GRAPHIC g922774snap121.jpg GRAPHIC 4014
7 GRAPHIC g922774sp2.jpg GRAPHIC 9057
  Complete submission text file 0001193125-20-286254.txt   812357
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249863 | Film No.: 201288736
SIC: 2834 Pharmaceutical Preparations